Who We Are
AI and Biology Experts
Elixinova is a biotechnology startup that utilizes artificial intelligence and a machine learning model to discover and develop new drugs for tackling diseases by learning about their protein binding interactions. Our team of passionate AI and biology experts is dedicated to enhancing the drug development process and revolutionizing healthcare. Founded by two Duke graduates in the United States, Elixinova prides itself on its great accuracy at predicting the protein binding between drugs and target disease molecules. Contact us to learn more about our innovative solutions in drug development.
Demo
In this demo, we will be using our model to predict the chances of a protein and a drug sequence binding with each other. Based on this, we can predict whether the drug can be used for the particular disease or not.
Our Approach
At Elixinova, our approach to drug discovery combines the power of artificial intelligence and biology to accelerate the development of new drugs. Our comprehensive technological solutions help pharmaceutical companies, research institutions, and healthcare organizations achieve greater success in the fight against diseases. We are continually building upon our technology to empower our users to do better. Stay in touch to learn about our latest developments.
Elixinova's AI drug discovery platform offers a versatile and customized approach to drug development. With a focus on accuracy and speed, our platform is equipped to handle a variety of use cases across the biotech industry. Our team works closely with you to ensure that you are getting the most out of the platform and providing you with the insights you need to make informed decisions.